Skip to content

Clinical Effect of Acupuncture in Neurodegenerative Diseases on Traumatic Brain Injury Patients

Clinical Effect of Acupuncture in Neurodegenerative Diseases on Traumatic Brain Injury Patients

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05839132
Enrollment
76
Registered
2023-05-03
Start date
2023-08-01
Completion date
2026-07-31
Last updated
2023-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurodegenerative Diseases

Keywords

Acupuncture, Traumatic Brain Injury

Brief summary

Traumatic brain injury (TBI) is an altered brain function caused by an external force, which may annually have 69 million incidence cases all over the world. Increasing evidence suggests that TBI may be a major risk of beta amyloid (Aβ)-associated neurodegenerative disorders, such as Alzheimer's disease, frontotemporal dementia, and Parkinson's disease. Investigations from brain imaging studies revealed that Aβ density maps of TBI patients overlapped with those with Alzheimer's disease, and increased Aβ density not only associated with prolonged TBI duration but also associated with decreased white matter integrity. It has been suggested that the axonal injury and cerebrovascular dysfunction due to TBI may associate with the elevated level of Aβ peptides. The increasing accumulation in Aβ due to TBI may contribute to the initiation of the pathological alterations in neurodegeneration diseases. Recent animal studies suggest that acupuncture may promote regeneration of nerves in injured tissues and reduce the concentration of Aβ in brain. Moreover, recent clinical trials also indicate that acupuncture may improve the vascular cognitive impairment due to cerebral small vessel disease. Thus, acupuncture treatment on TBI may not only be of benefit for the TBI recovery but also act to interrupt the pathological changes in these neurodegenerative diseases.

Interventions

PROCEDUREAcupuncture

20 minutes of acupuncture treatment, twice a week for 2 weeks. Acupoints will be manually stimulated every 10 minutes.

Sponsors

China Medical University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. age ≥ 20 years old 2. GCS score \> 8 3. loss of consciousness \< 24 hr 4. the physical condition is suitable for acupuncture treatment 5. having adequate competency for understanding the study and a willingness to sign the written informed consent forms 6. be able to commence the acupuncture intervention within 2 weeks after TBI diagnosis

Exclusion criteria

1. medical history of neurological, cardiovascular events, e.g., epilepsy, stroke, major depression or anxiety 2. a history of the mental disorder, e.g., major depression or anxiety 3. other major medical conditions, e.g., active cancer, uncontrolled diabetes, amputation 4. receipt of acupuncture within the 6 months prior to study entry 5. patients with pacemaker or metal graf

Design outcomes

Primary

MeasureTime frameDescription
plasma levels of Aβ peptideAfter 2-week acupuncture treatment intervaDecreased plasma levels of Aβ peptide
plasma levels of tauAfter 2-week acupuncture treatment intervaDecreased plasma levels of tau
plasma levels of glial fibrillary acidic protein (GFAP)After 2-week acupuncture treatment intervaDecreased plasma levels of glial fibrillary acidic protein (GFAP)

Countries

Taiwan

Contacts

Primary ContactYu-Chen Lee, Ph.D
d5167@mail.cmuh.org.tw+886-975-682023

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026